| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 8.68e-04 | 775 | 12 | 4 | GO:0017111 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 1.17e-03 | 839 | 12 | 4 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 1.17e-03 | 840 | 12 | 4 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 1.17e-03 | 840 | 12 | 4 | GO:0016818 | |
| GeneOntologyCellularComponent | basement membrane | 2.53e-03 | 122 | 13 | 2 | GO:0005604 | |
| Domain | AAA+_ATPase | 4.36e-03 | 144 | 13 | 2 | IPR003593 | |
| Domain | AAA | 4.36e-03 | 144 | 13 | 2 | SM00382 | |
| Domain | - | 1.01e-02 | 222 | 13 | 2 | 1.25.10.10 | |
| Domain | - | 1.34e-02 | 746 | 13 | 3 | 3.40.50.300 | |
| Domain | ARM-like | 1.46e-02 | 270 | 13 | 2 | IPR011989 | |
| Domain | P-loop_NTPase | 1.90e-02 | 848 | 13 | 3 | IPR027417 | |
| Domain | ARM-type_fold | 2.25e-02 | 339 | 13 | 2 | IPR016024 | |
| Pubmed | 1.93e-06 | 6 | 13 | 2 | 10982407 | ||
| Pubmed | The interactome of the prostate-specific protein Anoctamin 7. | 2.65e-04 | 65 | 13 | 2 | 32176628 | |
| Pubmed | Low BACH2 Expression Predicts Adverse Outcome in Chronic Lymphocytic Leukaemia. | 3.07e-04 | 70 | 13 | 2 | 35008187 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related-FDC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.19e-05 | 194 | 13 | 3 | f9fbb043411546d8c9e0321a64165d411f44aeb7 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.22e-05 | 195 | 13 | 3 | 1be9502577267ca2a04656a99d57e3e2f124d92e | |
| ToppCell | 356C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.36e-05 | 199 | 13 | 3 | f4fdf94c561dca35bb17766d908c5030655f43eb | |
| ToppCell | 356C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.36e-05 | 199 | 13 | 3 | c0fe99ed906d0eb99cccdab9a1fa32c17b3542e7 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.13e-04 | 138 | 13 | 2 | 8d70e64843f7c3be8ee4203cc126fdf1001f0df5 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.54e-04 | 142 | 13 | 2 | 5b6b0c611c83b23ef7289854a515b78f6cf84500 | |
| ToppCell | Epithelial-B_(AT1-AT2-progenitors)|World / shred on cell class and cell subclass (v4) | 7.97e-04 | 146 | 13 | 2 | 4511916904c1fac252cb68e871b782207f8137b3 | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgG_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | 8.63e-04 | 152 | 13 | 2 | a2ba2d95ac9010e1a62db34dcad10d004f8a90cc | |
| ToppCell | droplet-Liver-Npc-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.97e-04 | 155 | 13 | 2 | 5d600e159738231d0607ea1a1ebd8510fc241b36 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 8.97e-04 | 155 | 13 | 2 | 9d53caee196b5c2bbc90c4f54f693b64d4086065 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.09e-04 | 156 | 13 | 2 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.20e-04 | 157 | 13 | 2 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_cell|World / disease group, cell group and cell class (v2) | 9.32e-04 | 158 | 13 | 2 | afa8fa21c39c2192c1e23a4660011d63d58b733f | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-04 | 160 | 13 | 2 | 55f599df6e3b7a5a505df4b094c834281311d94a | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-04 | 160 | 13 | 2 | 296e53e1e0786346d38db2d4188b9a1c0430627b | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.79e-04 | 162 | 13 | 2 | d0d9c18a73bc0bf4f38308ef2eee8ae20f6a7918 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.79e-04 | 162 | 13 | 2 | 06f5d6c0bb26fe9d5180bc2ebf2c54bf52e715f3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.91e-04 | 163 | 13 | 2 | 51dee6c21cbeca4e17d1cc386e203f0c403089e8 | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_cell|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.00e-03 | 164 | 13 | 2 | e4d43af7eb04d55328791b554bdf3a7ce6818027 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Fibroblasts-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-03 | 165 | 13 | 2 | 15fd9d21dccfa80656a6fa3b72286a6a9252d403 | |
| ToppCell | metastatic_Brain-Fibroblasts-Smooth_muscle_cells|metastatic_Brain / Location, Cell class and cell subclass | 1.03e-03 | 166 | 13 | 2 | 0da2c6ea1e62f1aafabafbbfbbcc6f7011739346 | |
| ToppCell | ILEUM-non-inflamed-(4)_Mast|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.04e-03 | 167 | 13 | 2 | de0cb257def6049830af068f8f74829a708b810f | |
| ToppCell | ILEUM-non-inflamed-(4)_Mast_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.04e-03 | 167 | 13 | 2 | 85b39e05eb6e18e06b47e374d808e479ca65173c | |
| ToppCell | E17.5|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.06e-03 | 169 | 13 | 2 | 56aa58636ec624819ca88c8c27a7493c3f8c49fc | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-stromal_related-FDC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-03 | 169 | 13 | 2 | 49a54fb2ea9db5c45e107f304838c536908308bb | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 1.08e-03 | 170 | 13 | 2 | d69c0ea4cb6b204f19d0a5d2164afb42184779ac | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-03 | 171 | 13 | 2 | b6502a81df4f25660f3ae4b7443a1d999df2d32b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic-Mast_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-03 | 171 | 13 | 2 | ac37c80c832504986c7a201d84f4b6aff5e5f323 | |
| ToppCell | droplet-Heart-nan-18m-Hematologic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-03 | 171 | 13 | 2 | 2594ba8236a69461d9786ffcd882c39d0c9d5788 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.12e-03 | 173 | 13 | 2 | 3a39c7f290a9914fcf747e6bc6f13a509413b33c | |
| ToppCell | P07-Epithelial|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.12e-03 | 173 | 13 | 2 | 8b10087a917b825809d35a2b2b349c73a2782472 | |
| ToppCell | P03-Epithelial-epithelial_progenitor_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.13e-03 | 174 | 13 | 2 | 23c7fdfc73170cfc5cdee5bb7fbee0c8bbbbca07 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.13e-03 | 174 | 13 | 2 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | P07-Epithelial-alveolar_epithelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.13e-03 | 174 | 13 | 2 | 2739de68e0266054694f99807cfb1f07b6bbb371 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.14e-03 | 175 | 13 | 2 | 442f261a3b2c4d2523f7d4089178f8c79cac2f0f | |
| ToppCell | IIF-Lymphocyte-B-B_intermediate|IIF / Disease, Lineage and Cell Type | 1.14e-03 | 175 | 13 | 2 | 327f8ee3669c3fc5ba50abc3b4f3e068637fd8d8 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.14e-03 | 175 | 13 | 2 | 35fb7735dd3355476fe60404833cb60bd066bcf1 | |
| ToppCell | P03-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.14e-03 | 175 | 13 | 2 | a6d9ca35d3c4b4e3889d0a69b514f63ae630da6b | |
| ToppCell | facs-MAT-Fat-3m-Lymphocytic-T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-03 | 176 | 13 | 2 | 71b3309ddadd035a1224fca4fc5946dc4c0283fe | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-03 | 176 | 13 | 2 | 23bde9b9b4977b8cfe7d2a3ab8e8088ce9c6012c | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Mast_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-03 | 176 | 13 | 2 | 0d203682c372411ba64e97a8eae6c4788e8b6ecf | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-03 | 177 | 13 | 2 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.18e-03 | 178 | 13 | 2 | 066dbc4cc2083c549d98122ed44707127f34d582 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-03 | 178 | 13 | 2 | f332c7a96844abecf05ca057480fbea9296688a2 | |
| ToppCell | ASK440-Immune-Mast_cell|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.18e-03 | 178 | 13 | 2 | dcefc4afca3a40d1bd44722e66bca6b45a6c6c55 | |
| ToppCell | P15-Epithelial|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.19e-03 | 179 | 13 | 2 | 869d3d203e2cb88636e2f0c4476c72571ae3b5ca | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-03 | 179 | 13 | 2 | ca70a5518c5a5392e088c103e0cb44aa084f5332 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-03 | 179 | 13 | 2 | 40441de2d679733ecbf2145fabc3ed65a53310eb | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-03 | 179 | 13 | 2 | c451b074b04eb5d6c575c6abaedda579c6744bbf | |
| ToppCell | 367C-Myeloid-Mast_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-03 | 181 | 13 | 2 | 063fc83870f55f63c013f0276c1ec8f3abcbcf27 | |
| ToppCell | 367C-Myeloid-Mast_cell-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-03 | 181 | 13 | 2 | e1161c9828ee94518eb5bef0b6228d71299c2f59 | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|normal_Lung / Location, Cell class and cell subclass | 1.22e-03 | 181 | 13 | 2 | f74941e49950027360d71ea3b205fc20c6929766 | |
| ToppCell | P03-Epithelial|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.22e-03 | 181 | 13 | 2 | de0466072f5b2ab8db3d9bab31e3205d1ff7cfb7 | |
| ToppCell | P15-Epithelial-alveolar_epithelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.22e-03 | 181 | 13 | 2 | 7033be0ba90556f7e5f7c0d4a9f7644afcb22c9b | |
| ToppCell | P03-Epithelial-alveolar_epithelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.22e-03 | 181 | 13 | 2 | c3dbf8850d3812fbb770798f4cf38908db8bb92b | |
| ToppCell | droplet-Lung-nan-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-03 | 182 | 13 | 2 | cfba75c1ffc39ac76db9e8e27394731942882b30 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-DC-cDC2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.23e-03 | 182 | 13 | 2 | 1d37c486173cc4629842893ddd5033987c04086f | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.23e-03 | 182 | 13 | 2 | 0e52ba34e179d9bfaac7b49920b44c710b2b8dad | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.23e-03 | 182 | 13 | 2 | dc29e8735c3562ce32322351d28f7d9709208ebf | |
| ToppCell | droplet-Lung-nan-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-03 | 182 | 13 | 2 | 7e7c7a26460d3003cdf0c0ffb96208a566aa09a7 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-DC-cDC2-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.23e-03 | 182 | 13 | 2 | aef67bdc6937b315522d39959e26c9b0acf7ab52 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-03 | 182 | 13 | 2 | d836bfdc298ecd3558a973e393a329eb8bd59d79 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-DC|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.23e-03 | 182 | 13 | 2 | 087c9f88daf08f5d688b728c2386f91f210d2255 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-03 | 183 | 13 | 2 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | Immune_cells-small_pre-B.|World / Lineage and Cell class | 1.25e-03 | 183 | 13 | 2 | b6f9d2b2cf0f68b0a7779e0c0e0eef026cae86b6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.26e-03 | 184 | 13 | 2 | 29c95b814a0b1ad8734ed68b77df29c08594e5ec | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.26e-03 | 184 | 13 | 2 | ae0a77e3e520a246b17776bb19503519636b02ee | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.26e-03 | 184 | 13 | 2 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Mast_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.26e-03 | 184 | 13 | 2 | bc394eaa441fcaffcc4ace062741bca1da229324 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.26e-03 | 184 | 13 | 2 | e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.26e-03 | 184 | 13 | 2 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | P28-Epithelial|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.26e-03 | 184 | 13 | 2 | 05811d13bd8a602095a3fcf5e55345edadc7b8bf | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.26e-03 | 184 | 13 | 2 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.27e-03 | 185 | 13 | 2 | 3fafb1d36c5f98a29d20a5ce5192c83d6f603514 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_atypical-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.27e-03 | 185 | 13 | 2 | 53960307c6710401c3d52a766c3f4704ace9637f | |
| ToppCell | PND01-03-samps-Epithelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.27e-03 | 185 | 13 | 2 | 2b854df79cfe2cb4d2f9c2938a066e0aa3649325 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Mast_cells|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.27e-03 | 185 | 13 | 2 | a6e5328801c233a44153420e2cdae644b253f540 | |
| ToppCell | P28-Epithelial-alveolar_epithelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.27e-03 | 185 | 13 | 2 | 5bb513e569f3a197d55ae2ca683e202daebabeac | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-03 | 186 | 13 | 2 | fef543f188edb0d1704d9c6ace366a0f8017bf53 | |
| ToppCell | E17.5-Epithelial-alveolar_epithelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.29e-03 | 186 | 13 | 2 | a7a2ef8392a045a62fa4d0983577711d5d397dc4 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.29e-03 | 186 | 13 | 2 | de55471dd5c842026b409cfebf67fe32f079a011 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-03 | 186 | 13 | 2 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-03 | 186 | 13 | 2 | 77592a6397b44b2b59a4fc39d7224dd95343efe6 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-03 | 186 | 13 | 2 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.30e-03 | 187 | 13 | 2 | 406ff9327d3109fe1e251629c4c617b00a573dc2 | |
| ToppCell | E17.5-Epithelial|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.30e-03 | 187 | 13 | 2 | fdabe716ce67f2eede90548198cbe20bbf693570 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Undetermined|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.30e-03 | 187 | 13 | 2 | 55d5b21517c89736592982af40fd4cd64be62a3c | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.30e-03 | 187 | 13 | 2 | 23fe3cdd6cc9b067086a8392d104186d300298ea | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.30e-03 | 187 | 13 | 2 | 1aebf6fab40b96f2f5feb77a302bb805838fccf3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.30e-03 | 187 | 13 | 2 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.30e-03 | 187 | 13 | 2 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | ASK452-Immune-Mast_cell|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.31e-03 | 188 | 13 | 2 | 840215e16cff90f821f776186284eafcf2350690 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-03 | 188 | 13 | 2 | 8268574584e5fb869a6cb8bbd7135cd7454a6a25 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.31e-03 | 188 | 13 | 2 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-Mast_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-03 | 188 | 13 | 2 | 3fe9d698ff8f540edebf8609e7d42d3f81271edb | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-03 | 188 | 13 | 2 | 4544552ebd67e9eb3e40d8511bb2b03a6e1178f8 | |
| ToppCell | Mast_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.31e-03 | 188 | 13 | 2 | 229d24b87e945c4d543d11ac70761e45175ba0e5 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 1.31e-03 | 188 | 13 | 2 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | tumor_Lung-MAST_cells-MAST|tumor_Lung / Location, Cell class and cell subclass | 1.33e-03 | 189 | 13 | 2 | cd977962e01756b663728dae32ab9aba15bf7e22 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-03 | 189 | 13 | 2 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| Disease | neutrophil measurement | 2.27e-03 | 177 | 12 | 2 | EFO_0803548 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GKKGNEEKMKEGLED | 331 | Q8IUX8 | |
| DKKIEGEKHDMVRRG | 456 | Q8WYA6 | |
| KGDMVVSRVKGHKGE | 556 | P53420 | |
| GEMEKLEGKVHMKGS | 676 | O15438 | |
| HEGEVKAKEGRMEAK | 266 | Q96P66 | |
| MLKKFDKKDEESGGG | 1 | Q9Y678 | |
| GRIAKMHEVKGKDGV | 71 | Q96RP9 | |
| EEGEDKMKERKRHLG | 916 | Q5TCS8 | |
| GSGHKSEEKREKMKR | 21 | P41220 | |
| HDGEDTKMIVGEEKK | 236 | Q9H8M5 | |
| MLGKGGKRKFDEHED | 1 | Q14140 | |
| KGEGKSERKGKSEMQ | 71 | Q9H3H9 | |
| KGGDRKVEEEMKKHG | 446 | Q6S545 |